Background SLE is a complex autoimmune condition requiring evaluation across disease activity, permanent damage and ...
Objective Systemic lupus erythematosus Prospective Observational Cohort Study (SPOCS) was a prospective observational study ...
Patients with immune-mediated inflammatory diseases (IMIDs) are at increased risk of herpes zoster (HZ), particularly those with SLE, in whom HZ may be more frequent and severe.1 Recombinant zoster ...
Objective The long-term prognosis of patients with proliferative lupus nephritis (class III/IV) and low-level proteinuria remains unclear. Moreover, as some clinical trials have excluded them, the ...
Background Systemic lupus erythematosus (SLE) is a chronic, multisystem autoimmune disease characterised by diverse clinical manifestations that require multidisciplinary care. Across diverse care ...
Background Systemic lupus erythematosus (SLE) is a chronic autoimmune disease influenced by multiple factors. Growing evidence suggests that adverse childhood experiences (ACEs) and post-traumatic ...
Background SLE features aberrant type I interferon production, with the stimulator of interferon genes (STING) pathway acting as a key upstream driver. However, its expression patterns in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results